Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Semi-allogenic anti-tumour vaccine with HLA haplo-identical antigen-presenting cells

Semi-allogenic anti-tumour vaccine with HLA haplo-identical antigen-presenting cells

US Patent 9238063 · Granted Jan 19, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of detecting new immunogenic T cell epitopes and isolating new antigen-sp2025
T cell receptors and uses thereof2023
Method for generating antibodies against T cell receptor2022
Generation of antigen-specific TCRs2021
Method of detecting new immunogenic T cell epitopes and isolating new antigen-sp2021
Dendritic cell composition2021
T cell receptor library2020
High affinity T cell receptor and use thereof2020
High affinity T cell receptor and use thereof2018
Semi-allogenic anti-tumour vaccine with HLA haplo-identical antigen-presenting c2017
Semi-allogenic anti-tumour vaccine with HLA haplo-identical antigen-presenting c2017
Compositions for the preparation of mature dendritic cells2016